Hot Investor Mandate 4: Japan-Based Corporate Venture Arm Invests in Early-Stage Companies in the Biotech Therapeutics, Medical Technology and Devices, Diagnostics, and Healthcare IT Sectors

21 Dec

A venture arm of a Japan-based corporate with offices in Japan, China, India, and Silicon Valley makes seed, venture, and growth stage investments in companies in the life sciences space as well as other spaces like IT and cleantech. The firm typically makes equity investments in the range of $3-5M per portfolio company.

The firm primarily invests in life science companies based in the USA, but due to the firm’s global presence, the firm can also invest in companies based in China, Japan, India, and Europe. The firm has no current mandate for the number of allocations it plans to make in the space and will evaluate relevant opportunities as they surface.

The firm invests in early-stage companies in the biotech therapeutics, medical technology and devices, diagnostics, and healthcare IT sectors. The firm is sector and indication agnostic.

The firm is looking for companies with a strong and qualified management team or technical experts in the relevant technology. The firm can act as either a lead or co-investor.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s

%d bloggers like this: